Fear-Mongering and Stigmatizing Medications is Only Harming You and Your Community
<p>The current trend among the chronic pain community — unfortunately driven by some of their loudest advocates — is to stigmatize medications which can highly effective for many patients and for the right conditions. One of the main targets of this stigmatizing misinformation is buprenorphine. Why? Because buprenorphine is a partial-agonist opioid medication which is frequently used for the treatment of patients with substance use disorder, specifically opioid use disorder, for medication assisted recovery (MAR).</p>
<p>People within the chronic pain community understandably fear being stigmatized as patients with substance use disorder (PWSUD) and are pushing back strongly against the idea of buprenorphine — a partial-agonist opioid medication — being pushed on them to replace full-agonist opioid medications. I would be curious if the medication were used to treat a different and less stigmatized community, if folks would be stigmatizing a medication that can be used in their treatment the same way.</p>
<p><a href="https://tnicholsmd.medium.com/fear-mongering-and-stigmatizing-medications-is-only-harming-you-and-your-community-b97de52c4aa5"><strong>Visit Now</strong></a></p>